Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 30Th May, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations, 2015.
Astal Laboratories board approved Q4 and FY26 consolidated financial results. Consolidated Q4 revenue increased to ₹13,414.52 Lakhs with net profit at ₹767.99 Lakhs. M/s V R P S & Co. was re-appointed as internal auditors for FY27.
May 30 2026 21:03:20
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment
Astal Laboratories allotted 1.13 lakh equity shares at Rs. 40 per share to non-promoter warrant holders by converting warrants. This increases the company's paid-up equity capital by 0.26%.
May 26 2026 17:51:47
Astal Laboratories Ltd - 512600 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 30Th May, 2026.
Astal Laboratories' Board of Directors will meet on May 30, 2026, to consider and approve the audited Q4 FY26 and full-year financial results. The agenda also includes the appointment of an internal auditor for FY27.
May 25 2026 18:03:45
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Astal Laboratories announced the appointment of M/s. Khedar Ankur & Associates as the new statutory auditors for its material wholly owned subsidiary, Sriven Pharmachem India Private Limited, effective May 19, 2026. This appointment fills a casual vacancy created by the resignation of the previous auditors.
May 20 2026 14:03:10
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Astal Laboratories received a monitoring agency report confirming no deviation in the utilization of INR 276.87 crore funds from its preferential issue, aimed at acquiring Sriven Pharmachem India Limited to expand its product portfolio.
May 15 2026 17:47:42
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Astal Laboratories' material subsidiary, Sriven Pharmachem India Private Limited, announced the resignation of its statutory auditors, M/s. Balaji V & Co. The auditors resigned mid-term, effective May 13, 2026, as they do not possess a mandatory Peer Review Certificate required for auditing material subsidiaries, preventing them from completing the audit for the quarter and financial year ended March 31, 2026.
May 14 2026 12:16:10
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment
Astal Laboratories allotted 14.7 lakh equity shares at Rs. 40 each, upon conversion of warrants held by non-promoter investors. This issuance increases the company's paid-up capital by 3.48%.
May 12 2026 18:31:42
Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May, 2026.
Astal Laboratories allotted 1.47 million equity shares at Rs. 40 per share, totaling Rs. 4.41 crore, through the conversion of warrants. These shares were issued to 11 non-promoter investors.
May 12 2026 17:59:47
Read More